ArticleFrontiers in medicine2026
Elevated serum sortilin reflects inflammatory burden and coagulation dysfunction in ulcerative colitis.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sortilin, a multifunctional receptor, is implicated in inflammatory signaling; however, its clinical significance in ulcerative colitis (UC) remains unclear. This study evaluated serum sortilin levels in patients with UC and their associations with disease activity, inflammation, and coagulation. Methods: Serum sortilin, inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-17A, and IL-10), and coagulation indices (fibrinogen and D-dimer) were measured in patients with UC and healthy controls. Patients were stratified according to disease activity and severity. Correlations between serum sortilin levels and clinical, biochemical, and inflammatory parameters were assessed. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic value of serum sortilin. Results: Serum sortilin levels were significantly higher in patients with UC than in healthy controls ( Conclusion: Elevated serum sortilin levels are closely associated with disease activity, inflammatory cytokines, and coagulation parameters in UC, suggesting that sortilin may serve as a novel biomarker reflecting both inflammatory and hypercoagulable states in UC pathogenesis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.